Correlation Between Monte Rosa and Nuvalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Nuvalent, you can compare the effects of market volatilities on Monte Rosa and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Nuvalent.

Diversification Opportunities for Monte Rosa and Nuvalent

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monte and Nuvalent is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Monte Rosa i.e., Monte Rosa and Nuvalent go up and down completely randomly.

Pair Corralation between Monte Rosa and Nuvalent

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 2.87 times more return on investment than Nuvalent. However, Monte Rosa is 2.87 times more volatile than Nuvalent. It trades about 0.1 of its potential returns per unit of risk. Nuvalent is currently generating about 0.07 per unit of risk. If you would invest  582.00  in Monte Rosa Therapeutics on August 31, 2024 and sell it today you would earn a total of  329.00  from holding Monte Rosa Therapeutics or generate 56.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Nuvalent

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Nuvalent 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvalent are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Nuvalent disclosed solid returns over the last few months and may actually be approaching a breakup point.

Monte Rosa and Nuvalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Nuvalent

The main advantage of trading using opposite Monte Rosa and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.
The idea behind Monte Rosa Therapeutics and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets